Treatment with low doses of metformin for 14 days did not result in a significant inhibition of 4T1 tumour angiogenesis, as evidenced by the unaffected percentage of CD31+ area and number of vascular sprouts per vessel (Figure 2A‐C). The gene discussed is PECAM1; the disease is neoplasm.